Primera's Partnerships
with More to Come
By leveraging an innovative toolbox with the support of key strategic partners, Primera seeks to accelerate the development of mitochondrial disease treatments and rapidly support this undeserved patient population. Primera intends to work directly with Cellectis, CHOP, Mayo Clinic, UMDF and other collaborators, to bring potential treatments to clinic as fast as possible.
